Dr. Karimi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 2017 - 2020
- University of ChicagoResidency, Internal Medicine, 2014 - 2017
- Perelman School of Medicine at the University of PennsylvaniaClass of 2013
Certifications & Licensure
- MI State Medical License 2020 - 2026
- CA State Medical License 2017 - 2021
- IL State Medical License 2013 - 2017
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 15 citationsConsensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy.Jennifer L Crombie, Tara Graff, Lorenzo Falchi, Yasmin H Karimi, Rajat Bannerji
Blood. 2024-04-18 - 3 citationsAdding venetoclax to lenalidomide and rituximab is safe and effective in patients with untreated mantle cell lymphoma.Tycel J Phillips, David Bond, Radihka Takiar, Karson Kump, Malalthi Kandarpa
Blood Advances. 2023-08-22 - 7 citationsA phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.Kirk E. Cahill, Yasmin H. Karimi, Theodore Karrison, Nitin Jain, Margaret Green
Blood Advances. 2020-02-25
Press Mentions
- ASCO Announces CancerLinQ Discovery® Research Support Grant RecipientsAugust 15th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: